cyclin G2 Activators
Cyclin G2 Activators encompass a range of chemical compounds that indirectly facilitate the upregulation and functional enhancement of cyclin G2, a protein implicated in cell cycle regulation and growth control. Forskolin, for instance, by raising intracellular cAMP levels, indirectly augments cyclin G2 by activating PKA, which can phosphorylate and influence proteins associated with cyclin G2's regulatory network. Similarly, retinoic acid, through its impact on retinoid receptors, can modulate gene expression patterns to favor the cell cycle arrest capabilities of cyclin G2. The histone deacetylase inhibitor Trichostatin A may also enhance cyclin G2 activity by inducing a chromatin state that promotes the expression of genes responsible for cell cycle arrest. LY294002, a PI3K inhibitor, and Rapamycin, an mTOR inhibitor, both contribute to the indirect activation of pathways that can upregulate or enhance cyclin G2's function. Roscovitine and Olomoucine, both cyclin-dependent kinase inhibitors, are thought to bolster cyclin G2's role by inhibiting competing kinase activities that would otherwise suppress its cell cycle regulatory function.
Cyclin G2 Activators encompass a range of chemical compounds that indirectly facilitate the upregulation and functional enhancement of cyclin G2, a protein implicated in cell cycle regulation and growth control. Forskolin, for instance, by raising intracellular cAMP levels, indirectly augments cyclin G2 by activating PKA, which can phosphorylate and influence proteins associated with cyclin G2's regulatory network. Similarly, retinoic acid, through its impact on retinoid receptors, can modulate gene expression patterns to favor the cell cycle arrest capabilities of cyclin G2. The histone deacetylase inhibitor Trichostatin A may also enhance cyclin G2 activity by inducing a chromatin state that promotes the expression of genes responsible for cell cycle arrest. LY294002, a PI3K inhibitor, and Rapamycin, an mTOR inhibitor, both contribute to the indirect activation of pathways that can upregulate or enhance cyclin G2's
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which in turn activates PKA. PKA can phosphorylate a variety of proteins, potentially including factors that interact with cyclin G2, thereby enhancing its activity in cell cycle regulation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid modulates retinoid receptors, which can alter gene expression patterns. This modulation may upregulate proteins that are part of the cyclin G2 regulatory network, enhancing its cell cycle arrest functions. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases (HDACs), which leads to a more relaxed chromatin structure and can increase the expression of genes involved in cell cycle arrest, possibly enhancing the activity of cyclin G2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that indirectly can lead to the activation of FOXO transcription factors. FOXO can increase the expression of genes involved in the cell cycle arrest, including those that could enhance cyclin G2 activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can alter the MAPK/ERK pathway, potentially leading to an increase in proteins that favor cell cycle arrest, which may include functional partners of cyclin G2, enhancing its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which can result in the activation of autophagy-related pathways. This could enhance the degradation of proteins that negatively regulate cyclin G2, thereby indirectly increasing its activity. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a cyclin-dependent kinase inhibitor that could inhibit cyclin/CDK complexes which phosphorylate and inactivate proteins that interact with cyclin G2, potentially enhancing its role in cell cycle control. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates sirtuins, particularly SIRT1, which can deacetylate proteins involved in cell cycle arrest and longevity pathways, possibly leading to an enhancement of cyclin G2 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that could shift cellular responses towards cell cycle arrest by influencing transcription factors and proteins that interact with or regulate cyclin G2 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which could lead to alterations in cellular stress response pathways, potentially enhancing the activity of cyclin G2 in cell cycle regulation. | ||||||